Results 61 to 70 of about 1,282,898 (189)

Cancer in pregnancy: FIGO Best practice advice and narrative review

International Journal of Gynecology &Obstetrics, Volume 171, Issue 1, Page 131-151, October 2025.
Abstract Cancer during pregnancy is relatively rare. The incidence is underestimated due to the lack of international registries covering both high‐income and low‐ and middle‐income countries, and is expected to rise with increasing maternal age and increasing global adoption of cell‐free DNA testing for aneuploidy.
Surabhi Nanda, Melanie Nana, Long Nguyen‐Hoang, Sumaiya Adam, Fionnuala McAuliffe, Lina Bergman, Sarikapan Wilailak, Orla McNally, Cynthia V. Maxwell, Nikhil Purandare, Bo Jacobsson, Virna P. Medina, Anil Kapur, Titus Beyuo, Francisco Ruiloba, Ernesto Castelazo, Graeme N. Smith, Sharleen L. O'Reilly, Patrick O'Brien, Mark Hanson, Mary L. Rosser, Claudio Sosa, Valerie Guinto, Jonathan Berek, Catherine Nelson‐Piercy, Frédéric Amant, Liona Poon, on behalf of the FIGO Committee on the Impact of Pregnancy on Long‐term Health, FIGO Committee on Women's Cancer, and the FIGO Division of Maternal and Newborn Health   +29 more
wiley   +1 more source

Cancer of the cervix uteri: 2025 update

International Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 87-108, September 2025.
Abstract Since the publication of the 2021 FIGO Cancer Report, there has been further progress in the global effort to attain the WHO goal of cervical cancer elimination using a three‐pillar approach of vaccination, screening, and treatment. The HPV vaccination is now included in the national program of over 140 countries.
Neerja Bhatla, Daisuke Aoki, Daya Nand Sharma, Rengaswamy Sankaranarayanan   +3 more
wiley   +1 more source

Characteristics, Management and Survival Rate of Ovarian Germ Cell Tumor

Indonesian Journal of Obstetrics and Gynecology, 2019
Objective:To determine the prevalence of malignant ovarian germ cell tumour in term of characteristics, management, and 3-year survival rate in Dr. Cipto Mangunkusumo Hospital Jakarta from 2011 to 2013.
Laila Nuranna, Zakiah Tourik
doaj   +1 more source

Cancer of the ovary, fallopian tube, and peritoneum: 2025 update

International Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 6-35, September 2025.
Abstract In 2014, FIGO's Committee for Gynecologic Oncology revised the staging of ovarian cancer, incorporating ovarian, fallopian tube, and peritoneal cancer into the same system. Most of these malignancies are high‐grade serous carcinomas (HGSCs).
Malte Renz, Michael Friedlander, Jonathan S. Berek   +2 more
wiley   +1 more source

Childhood Cancer Survivors in Latin America: Insights Into Health Outcomes and Information Needs

Pediatric Blood &Cancer, Volume 72, Issue 9, September 2025.
ABSTRACT Background Childhood cancer survivors (CCSs) face long‐term health challenges, yet the health and specific needs of Latin American survivors remain underexplored. This study aimed to describe the health‐related, psychosocial late effects, and information needs among CCSs in the region. Methods This mixed‐method study combined quantitative data
Ana Carolina Izurieta‐Pacheco, David H. Noyd, Julia Challinor, Nuria Rossell, Maria Fernanda Olarte‐Sierra, Daniel Bastardo Blanco, Marcela Zubieta, Nicholas B. George, Sara Perez‐Jaume, Anna Felip‐Badia, Viviana Trigoso, Patricia Loggetto, Valeska Gonzalez, Carlos Frias, Sinders Rincon, Roberta Ortiz, Soad Fuentes‐Alabi de Aparicio, Liliana Vásquez Ponce   +17 more
wiley   +1 more source

Tracing the Evolution of Sex Hormones and Receptor‐Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease

Advanced Science, Volume 12, Issue 13, April 3, 2025.
Prostate and bladder cancers activate genes and pathways similar to those in the developmental stage by aggregating and analyzing current data. In this process, sex hormones and their receptors maybe a key role in causing and reversing the “cold” and “hot” immune tumor phenotypes, potentially enhancing the immune response.
Dengxiong Li, Zhipeng Wang, Qingxin Yu, Jie Wang, Ruicheng Wu, Zhouting Tuo, Koo Han Yoo, Dilinaer Wusiman, Luxia Ye, Yiqing Guo, Yubo Yang, Fanglin Shao, Ziyu Shu, Uzoamaka Okoli, William C. Cho, Wuran Wei, Dechao Feng   +16 more
wiley   +1 more source

Application of Nanomaterials in the Repair and Regeneration of Lymphatic Organs and Corresponding Biophysical Simulation Strategies

Advanced NanoBiomed Research, Volume 5, Issue 2, February 2025.
Immune system diseases, tumors, and injuries can damage lymphoid organs and impair immune function. Treatments like chemotherapy and radiotherapy exacerbate these issues, leading to dysfunction and increased infection risk. Nanotechnology plays a crucial role in regenerating lymphoid organs and restoring immune function through targeted drug delivery ...
Bangheng Liu, Dong‐An Wang
wiley   +1 more source

Endodermal Sinus Tumor in a 14-Year-Old Girl [PDF]

, 1986
A case report on a 14-year-old girl with a large pelvic and abdominal mass is presented. Initial evaluation suggested the mass to be of ovarian origin, and the diagnosis of endodermal sinus tumor was confirmed by the pathological specimen.
Padda, Roshinder, Boyce, Lorenzo C., Balchandani, Kiran   +2 more
core   +1 more source

Vaginoscopy to investigate vaginal bleeding and discharge in prepubertal girls

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 65, Issue 1, Page 140-146, February 2025.
Study Objective To investigate the aetiology of vaginal bleeding and discharge in prepubescent girls, and the utility of vaginoscopy for making a diagnosis. Design Retrospective observational study over 14 years. Setting Two major tertiary referral paediatric hospitals in Sydney, Australia.
Asha Short, Andrea Sit, Brigitte Gerstl, Hayley Mallinder, Rebecca Deans   +4 more
wiley   +1 more source

Predicting Drug Targets in Human Cancers

Journal of Clinical Pharmacy and Therapeutics, Volume 2025, Issue 1, 2025.
Introduction A large amount of knowledge has accumulated regarding the pharmacology of most cancer types, including their side effects, and during the last decade, many novel agents have emerged, accompanied by increased costs for healthcare systems. Aim Artificial intelligence (AI) was applied in healthcare services, and the benefit of its use in the ...
David Calderón Guzmán, Norma Osnaya Brizuela, Armando Valenzuela Peraza, Maribel Ortiz Herrera, Diego E. Ortega Garcia, Hugo Juarez Olguin, Gerardo Barragán Mejía, Md Saquib Hasnain   +7 more
wiley   +1 more source